<LCTL_TEXT lang="spa">
<DOC grammar="none" id="L0C04CVL2" lang="spa" raw_text_char_length="2448" raw_text_md5="4d68fa74c9a07fbf6b90670d636065e8" tokenization="tokenization_parameters.v5.0">
<TEXT>
<SEG end_char="75" id="segment-0" start_char="1">
<ORIGINAL_TEXT>Autorización de uso de emergencia del fármaco Bamlanivimab para la COVID-19</ORIGINAL_TEXT>
<TOKEN end_char="12" id="token-0-0" morph="none" pos="word" start_char="1">Autorización</TOKEN>
<TOKEN end_char="15" id="token-0-1" morph="none" pos="word" start_char="14">de</TOKEN>
<TOKEN end_char="19" id="token-0-2" morph="none" pos="word" start_char="17">uso</TOKEN>
<TOKEN end_char="22" id="token-0-3" morph="none" pos="word" start_char="21">de</TOKEN>
<TOKEN end_char="33" id="token-0-4" morph="none" pos="word" start_char="24">emergencia</TOKEN>
<TOKEN end_char="37" id="token-0-5" morph="none" pos="word" start_char="35">del</TOKEN>
<TOKEN end_char="45" id="token-0-6" morph="none" pos="word" start_char="39">fármaco</TOKEN>
<TOKEN end_char="58" id="token-0-7" morph="none" pos="word" start_char="47">Bamlanivimab</TOKEN>
<TOKEN end_char="63" id="token-0-8" morph="none" pos="word" start_char="60">para</TOKEN>
<TOKEN end_char="66" id="token-0-9" morph="none" pos="word" start_char="65">la</TOKEN>
<TOKEN end_char="75" id="token-0-10" morph="none" pos="unknown" start_char="68">COVID-19</TOKEN>
<TRANSLATED_TEXT>Emergency use authorization of the drug Bamlanivimab for COVID-19</TRANSLATED_TEXT><DETECTED_LANGUAGE>es</DETECTED_LANGUAGE></SEG>
<SEG end_char="312" id="segment-1" start_char="80">
<ORIGINAL_TEXT>La Administración de Alimentos y Medicamentos (FDA, por sus siglas en inglés) de los Estados Unidos, ha emitido una autorización de uso de emergencia (EUA, por sus siglas en inglés) para bamlanivimab en el tratamiento de la COVID-19.</ORIGINAL_TEXT>
<TOKEN end_char="81" id="token-1-0" morph="none" pos="word" start_char="80">La</TOKEN>
<TOKEN end_char="96" id="token-1-1" morph="none" pos="word" start_char="83">Administración</TOKEN>
<TOKEN end_char="99" id="token-1-2" morph="none" pos="word" start_char="98">de</TOKEN>
<TOKEN end_char="109" id="token-1-3" morph="none" pos="word" start_char="101">Alimentos</TOKEN>
<TOKEN end_char="111" id="token-1-4" morph="none" pos="word" start_char="111">y</TOKEN>
<TOKEN end_char="124" id="token-1-5" morph="none" pos="word" start_char="113">Medicamentos</TOKEN>
<TOKEN end_char="126" id="token-1-6" morph="none" pos="punct" start_char="126">(</TOKEN>
<TOKEN end_char="129" id="token-1-7" morph="none" pos="word" start_char="127">FDA</TOKEN>
<TOKEN end_char="130" id="token-1-8" morph="none" pos="punct" start_char="130">,</TOKEN>
<TOKEN end_char="134" id="token-1-9" morph="none" pos="word" start_char="132">por</TOKEN>
<TOKEN end_char="138" id="token-1-10" morph="none" pos="word" start_char="136">sus</TOKEN>
<TOKEN end_char="145" id="token-1-11" morph="none" pos="word" start_char="140">siglas</TOKEN>
<TOKEN end_char="148" id="token-1-12" morph="none" pos="word" start_char="147">en</TOKEN>
<TOKEN end_char="155" id="token-1-13" morph="none" pos="word" start_char="150">inglés</TOKEN>
<TOKEN end_char="156" id="token-1-14" morph="none" pos="punct" start_char="156">)</TOKEN>
<TOKEN end_char="159" id="token-1-15" morph="none" pos="word" start_char="158">de</TOKEN>
<TOKEN end_char="163" id="token-1-16" morph="none" pos="word" start_char="161">los</TOKEN>
<TOKEN end_char="171" id="token-1-17" morph="none" pos="word" start_char="165">Estados</TOKEN>
<TOKEN end_char="178" id="token-1-18" morph="none" pos="word" start_char="173">Unidos</TOKEN>
<TOKEN end_char="179" id="token-1-19" morph="none" pos="punct" start_char="179">,</TOKEN>
<TOKEN end_char="182" id="token-1-20" morph="none" pos="word" start_char="181">ha</TOKEN>
<TOKEN end_char="190" id="token-1-21" morph="none" pos="word" start_char="184">emitido</TOKEN>
<TOKEN end_char="194" id="token-1-22" morph="none" pos="word" start_char="192">una</TOKEN>
<TOKEN end_char="207" id="token-1-23" morph="none" pos="word" start_char="196">autorización</TOKEN>
<TOKEN end_char="210" id="token-1-24" morph="none" pos="word" start_char="209">de</TOKEN>
<TOKEN end_char="214" id="token-1-25" morph="none" pos="word" start_char="212">uso</TOKEN>
<TOKEN end_char="217" id="token-1-26" morph="none" pos="word" start_char="216">de</TOKEN>
<TOKEN end_char="228" id="token-1-27" morph="none" pos="word" start_char="219">emergencia</TOKEN>
<TOKEN end_char="230" id="token-1-28" morph="none" pos="punct" start_char="230">(</TOKEN>
<TOKEN end_char="233" id="token-1-29" morph="none" pos="word" start_char="231">EUA</TOKEN>
<TOKEN end_char="234" id="token-1-30" morph="none" pos="punct" start_char="234">,</TOKEN>
<TOKEN end_char="238" id="token-1-31" morph="none" pos="word" start_char="236">por</TOKEN>
<TOKEN end_char="242" id="token-1-32" morph="none" pos="word" start_char="240">sus</TOKEN>
<TOKEN end_char="249" id="token-1-33" morph="none" pos="word" start_char="244">siglas</TOKEN>
<TOKEN end_char="252" id="token-1-34" morph="none" pos="word" start_char="251">en</TOKEN>
<TOKEN end_char="259" id="token-1-35" morph="none" pos="word" start_char="254">inglés</TOKEN>
<TOKEN end_char="260" id="token-1-36" morph="none" pos="punct" start_char="260">)</TOKEN>
<TOKEN end_char="265" id="token-1-37" morph="none" pos="word" start_char="262">para</TOKEN>
<TOKEN end_char="278" id="token-1-38" morph="none" pos="word" start_char="267">bamlanivimab</TOKEN>
<TOKEN end_char="281" id="token-1-39" morph="none" pos="word" start_char="280">en</TOKEN>
<TOKEN end_char="284" id="token-1-40" morph="none" pos="word" start_char="283">el</TOKEN>
<TOKEN end_char="296" id="token-1-41" morph="none" pos="word" start_char="286">tratamiento</TOKEN>
<TOKEN end_char="299" id="token-1-42" morph="none" pos="word" start_char="298">de</TOKEN>
<TOKEN end_char="302" id="token-1-43" morph="none" pos="word" start_char="301">la</TOKEN>
<TOKEN end_char="311" id="token-1-44" morph="none" pos="unknown" start_char="304">COVID-19</TOKEN>
<TOKEN end_char="312" id="token-1-45" morph="none" pos="punct" start_char="312">.</TOKEN>
<TRANSLATED_TEXT>The U.S. Food and Drug Administration (FDA) has issued an emergency use authorization (US) for bamlanivimab in the treatment of COVID-19.</TRANSLATED_TEXT><DETECTED_LANGUAGE>es</DETECTED_LANGUAGE></SEG>
<SEG end_char="572" id="segment-2" start_char="315">
<ORIGINAL_TEXT>El bamlanivimab es un anticuerpo monoclonal que consta de 2 polipéptidos de cadena ligera idénticos y se dirige específicamente contra la proteína de pico del SARS-CoV-2, que está diseñado para bloquear la unión del virus y su entrada en las células humanas.</ORIGINAL_TEXT>
<TOKEN end_char="316" id="token-2-0" morph="none" pos="word" start_char="315">El</TOKEN>
<TOKEN end_char="329" id="token-2-1" morph="none" pos="word" start_char="318">bamlanivimab</TOKEN>
<TOKEN end_char="332" id="token-2-2" morph="none" pos="word" start_char="331">es</TOKEN>
<TOKEN end_char="335" id="token-2-3" morph="none" pos="word" start_char="334">un</TOKEN>
<TOKEN end_char="346" id="token-2-4" morph="none" pos="word" start_char="337">anticuerpo</TOKEN>
<TOKEN end_char="357" id="token-2-5" morph="none" pos="word" start_char="348">monoclonal</TOKEN>
<TOKEN end_char="361" id="token-2-6" morph="none" pos="word" start_char="359">que</TOKEN>
<TOKEN end_char="368" id="token-2-7" morph="none" pos="word" start_char="363">consta</TOKEN>
<TOKEN end_char="371" id="token-2-8" morph="none" pos="word" start_char="370">de</TOKEN>
<TOKEN end_char="373" id="token-2-9" morph="none" pos="word" start_char="373">2</TOKEN>
<TOKEN end_char="386" id="token-2-10" morph="none" pos="word" start_char="375">polipéptidos</TOKEN>
<TOKEN end_char="389" id="token-2-11" morph="none" pos="word" start_char="388">de</TOKEN>
<TOKEN end_char="396" id="token-2-12" morph="none" pos="word" start_char="391">cadena</TOKEN>
<TOKEN end_char="403" id="token-2-13" morph="none" pos="word" start_char="398">ligera</TOKEN>
<TOKEN end_char="413" id="token-2-14" morph="none" pos="word" start_char="405">idénticos</TOKEN>
<TOKEN end_char="415" id="token-2-15" morph="none" pos="word" start_char="415">y</TOKEN>
<TOKEN end_char="418" id="token-2-16" morph="none" pos="word" start_char="417">se</TOKEN>
<TOKEN end_char="425" id="token-2-17" morph="none" pos="word" start_char="420">dirige</TOKEN>
<TOKEN end_char="441" id="token-2-18" morph="none" pos="word" start_char="427">específicamente</TOKEN>
<TOKEN end_char="448" id="token-2-19" morph="none" pos="word" start_char="443">contra</TOKEN>
<TOKEN end_char="451" id="token-2-20" morph="none" pos="word" start_char="450">la</TOKEN>
<TOKEN end_char="460" id="token-2-21" morph="none" pos="word" start_char="453">proteína</TOKEN>
<TOKEN end_char="463" id="token-2-22" morph="none" pos="word" start_char="462">de</TOKEN>
<TOKEN end_char="468" id="token-2-23" morph="none" pos="word" start_char="465">pico</TOKEN>
<TOKEN end_char="472" id="token-2-24" morph="none" pos="word" start_char="470">del</TOKEN>
<TOKEN end_char="483" id="token-2-25" morph="none" pos="unknown" start_char="474">SARS-CoV-2</TOKEN>
<TOKEN end_char="484" id="token-2-26" morph="none" pos="punct" start_char="484">,</TOKEN>
<TOKEN end_char="488" id="token-2-27" morph="none" pos="word" start_char="486">que</TOKEN>
<TOKEN end_char="493" id="token-2-28" morph="none" pos="word" start_char="490">está</TOKEN>
<TOKEN end_char="502" id="token-2-29" morph="none" pos="word" start_char="495">diseñado</TOKEN>
<TOKEN end_char="507" id="token-2-30" morph="none" pos="word" start_char="504">para</TOKEN>
<TOKEN end_char="516" id="token-2-31" morph="none" pos="word" start_char="509">bloquear</TOKEN>
<TOKEN end_char="519" id="token-2-32" morph="none" pos="word" start_char="518">la</TOKEN>
<TOKEN end_char="525" id="token-2-33" morph="none" pos="word" start_char="521">unión</TOKEN>
<TOKEN end_char="529" id="token-2-34" morph="none" pos="word" start_char="527">del</TOKEN>
<TOKEN end_char="535" id="token-2-35" morph="none" pos="word" start_char="531">virus</TOKEN>
<TOKEN end_char="537" id="token-2-36" morph="none" pos="word" start_char="537">y</TOKEN>
<TOKEN end_char="540" id="token-2-37" morph="none" pos="word" start_char="539">su</TOKEN>
<TOKEN end_char="548" id="token-2-38" morph="none" pos="word" start_char="542">entrada</TOKEN>
<TOKEN end_char="551" id="token-2-39" morph="none" pos="word" start_char="550">en</TOKEN>
<TOKEN end_char="555" id="token-2-40" morph="none" pos="word" start_char="553">las</TOKEN>
<TOKEN end_char="563" id="token-2-41" morph="none" pos="word" start_char="557">células</TOKEN>
<TOKEN end_char="571" id="token-2-42" morph="none" pos="word" start_char="565">humanas</TOKEN>
<TOKEN end_char="572" id="token-2-43" morph="none" pos="punct" start_char="572">.</TOKEN>
<TRANSLATED_TEXT>Bamlanivimab is a monoclonal antibody consisting of 2 identical light-chain polypeptides and directed specifically against the SARS-CoV-2 peak protein, which is designed to block the virus's binding and entry into human cells.</TRANSLATED_TEXT><DETECTED_LANGUAGE>es</DETECTED_LANGUAGE></SEG>
<SEG end_char="671" id="segment-3" start_char="574">
<ORIGINAL_TEXT>Los anticuerpos monoclonales son proteínas del sistema inmunitario que se crean en el laboratorio.</ORIGINAL_TEXT>
<TOKEN end_char="576" id="token-3-0" morph="none" pos="word" start_char="574">Los</TOKEN>
<TOKEN end_char="588" id="token-3-1" morph="none" pos="word" start_char="578">anticuerpos</TOKEN>
<TOKEN end_char="601" id="token-3-2" morph="none" pos="word" start_char="590">monoclonales</TOKEN>
<TOKEN end_char="605" id="token-3-3" morph="none" pos="word" start_char="603">son</TOKEN>
<TOKEN end_char="615" id="token-3-4" morph="none" pos="word" start_char="607">proteínas</TOKEN>
<TOKEN end_char="619" id="token-3-5" morph="none" pos="word" start_char="617">del</TOKEN>
<TOKEN end_char="627" id="token-3-6" morph="none" pos="word" start_char="621">sistema</TOKEN>
<TOKEN end_char="639" id="token-3-7" morph="none" pos="word" start_char="629">inmunitario</TOKEN>
<TOKEN end_char="643" id="token-3-8" morph="none" pos="word" start_char="641">que</TOKEN>
<TOKEN end_char="646" id="token-3-9" morph="none" pos="word" start_char="645">se</TOKEN>
<TOKEN end_char="652" id="token-3-10" morph="none" pos="word" start_char="648">crean</TOKEN>
<TOKEN end_char="655" id="token-3-11" morph="none" pos="word" start_char="654">en</TOKEN>
<TOKEN end_char="658" id="token-3-12" morph="none" pos="word" start_char="657">el</TOKEN>
<TOKEN end_char="670" id="token-3-13" morph="none" pos="word" start_char="660">laboratorio</TOKEN>
<TOKEN end_char="671" id="token-3-14" morph="none" pos="punct" start_char="671">.</TOKEN>
<TRANSLATED_TEXT>Monoclonal antibodies are immune system proteins that are created in the laboratory.</TRANSLATED_TEXT><DETECTED_LANGUAGE>es</DETECTED_LANGUAGE></SEG>
<SEG end_char="1280" id="segment-4" start_char="674">
<ORIGINAL_TEXT>Bamlanivimab está autorizado para el tratamiento de la Covid-19 de leve a moderado, en pacientes adultos y pediátricos con resultados positivos a pruebas virales directas del SARS-CoV-2, que tengan 12 años de edad o más y pesen al menos 40 kg, con un alto riesgo de progresar a COVID-19 grave y/o de hospitalización (con al menos uno de los siguiente criterios: un IMC ≥35, enfermedad renal crónica, diabetes, una enfermedad inmunosupresora, reciben tratamiento inmunosupresor, ≥65 años, ≥55 años que tiene enfermedad cardiovascular, hipertensión o una enfermedad pulmonar obstructiva crónica, entre otros).</ORIGINAL_TEXT>
<TOKEN end_char="685" id="token-4-0" morph="none" pos="word" start_char="674">Bamlanivimab</TOKEN>
<TOKEN end_char="690" id="token-4-1" morph="none" pos="word" start_char="687">está</TOKEN>
<TOKEN end_char="701" id="token-4-2" morph="none" pos="word" start_char="692">autorizado</TOKEN>
<TOKEN end_char="706" id="token-4-3" morph="none" pos="word" start_char="703">para</TOKEN>
<TOKEN end_char="709" id="token-4-4" morph="none" pos="word" start_char="708">el</TOKEN>
<TOKEN end_char="721" id="token-4-5" morph="none" pos="word" start_char="711">tratamiento</TOKEN>
<TOKEN end_char="724" id="token-4-6" morph="none" pos="word" start_char="723">de</TOKEN>
<TOKEN end_char="727" id="token-4-7" morph="none" pos="word" start_char="726">la</TOKEN>
<TOKEN end_char="736" id="token-4-8" morph="none" pos="unknown" start_char="729">Covid-19</TOKEN>
<TOKEN end_char="739" id="token-4-9" morph="none" pos="word" start_char="738">de</TOKEN>
<TOKEN end_char="744" id="token-4-10" morph="none" pos="word" start_char="741">leve</TOKEN>
<TOKEN end_char="746" id="token-4-11" morph="none" pos="word" start_char="746">a</TOKEN>
<TOKEN end_char="755" id="token-4-12" morph="none" pos="word" start_char="748">moderado</TOKEN>
<TOKEN end_char="756" id="token-4-13" morph="none" pos="punct" start_char="756">,</TOKEN>
<TOKEN end_char="759" id="token-4-14" morph="none" pos="word" start_char="758">en</TOKEN>
<TOKEN end_char="769" id="token-4-15" morph="none" pos="word" start_char="761">pacientes</TOKEN>
<TOKEN end_char="777" id="token-4-16" morph="none" pos="word" start_char="771">adultos</TOKEN>
<TOKEN end_char="779" id="token-4-17" morph="none" pos="word" start_char="779">y</TOKEN>
<TOKEN end_char="791" id="token-4-18" morph="none" pos="word" start_char="781">pediátricos</TOKEN>
<TOKEN end_char="795" id="token-4-19" morph="none" pos="word" start_char="793">con</TOKEN>
<TOKEN end_char="806" id="token-4-20" morph="none" pos="word" start_char="797">resultados</TOKEN>
<TOKEN end_char="816" id="token-4-21" morph="none" pos="word" start_char="808">positivos</TOKEN>
<TOKEN end_char="818" id="token-4-22" morph="none" pos="word" start_char="818">a</TOKEN>
<TOKEN end_char="826" id="token-4-23" morph="none" pos="word" start_char="820">pruebas</TOKEN>
<TOKEN end_char="834" id="token-4-24" morph="none" pos="word" start_char="828">virales</TOKEN>
<TOKEN end_char="843" id="token-4-25" morph="none" pos="word" start_char="836">directas</TOKEN>
<TOKEN end_char="847" id="token-4-26" morph="none" pos="word" start_char="845">del</TOKEN>
<TOKEN end_char="858" id="token-4-27" morph="none" pos="unknown" start_char="849">SARS-CoV-2</TOKEN>
<TOKEN end_char="859" id="token-4-28" morph="none" pos="punct" start_char="859">,</TOKEN>
<TOKEN end_char="863" id="token-4-29" morph="none" pos="word" start_char="861">que</TOKEN>
<TOKEN end_char="870" id="token-4-30" morph="none" pos="word" start_char="865">tengan</TOKEN>
<TOKEN end_char="873" id="token-4-31" morph="none" pos="word" start_char="872">12</TOKEN>
<TOKEN end_char="878" id="token-4-32" morph="none" pos="word" start_char="875">años</TOKEN>
<TOKEN end_char="881" id="token-4-33" morph="none" pos="word" start_char="880">de</TOKEN>
<TOKEN end_char="886" id="token-4-34" morph="none" pos="word" start_char="883">edad</TOKEN>
<TOKEN end_char="888" id="token-4-35" morph="none" pos="word" start_char="888">o</TOKEN>
<TOKEN end_char="892" id="token-4-36" morph="none" pos="word" start_char="890">más</TOKEN>
<TOKEN end_char="894" id="token-4-37" morph="none" pos="word" start_char="894">y</TOKEN>
<TOKEN end_char="900" id="token-4-38" morph="none" pos="word" start_char="896">pesen</TOKEN>
<TOKEN end_char="903" id="token-4-39" morph="none" pos="word" start_char="902">al</TOKEN>
<TOKEN end_char="909" id="token-4-40" morph="none" pos="word" start_char="905">menos</TOKEN>
<TOKEN end_char="912" id="token-4-41" morph="none" pos="word" start_char="911">40</TOKEN>
<TOKEN end_char="915" id="token-4-42" morph="none" pos="word" start_char="914">kg</TOKEN>
<TOKEN end_char="916" id="token-4-43" morph="none" pos="punct" start_char="916">,</TOKEN>
<TOKEN end_char="920" id="token-4-44" morph="none" pos="word" start_char="918">con</TOKEN>
<TOKEN end_char="923" id="token-4-45" morph="none" pos="word" start_char="922">un</TOKEN>
<TOKEN end_char="928" id="token-4-46" morph="none" pos="word" start_char="925">alto</TOKEN>
<TOKEN end_char="935" id="token-4-47" morph="none" pos="word" start_char="930">riesgo</TOKEN>
<TOKEN end_char="938" id="token-4-48" morph="none" pos="word" start_char="937">de</TOKEN>
<TOKEN end_char="948" id="token-4-49" morph="none" pos="word" start_char="940">progresar</TOKEN>
<TOKEN end_char="950" id="token-4-50" morph="none" pos="word" start_char="950">a</TOKEN>
<TOKEN end_char="959" id="token-4-51" morph="none" pos="unknown" start_char="952">COVID-19</TOKEN>
<TOKEN end_char="965" id="token-4-52" morph="none" pos="word" start_char="961">grave</TOKEN>
<TOKEN end_char="969" id="token-4-53" morph="none" pos="unknown" start_char="967">y/o</TOKEN>
<TOKEN end_char="972" id="token-4-54" morph="none" pos="word" start_char="971">de</TOKEN>
<TOKEN end_char="988" id="token-4-55" morph="none" pos="word" start_char="974">hospitalización</TOKEN>
<TOKEN end_char="990" id="token-4-56" morph="none" pos="punct" start_char="990">(</TOKEN>
<TOKEN end_char="993" id="token-4-57" morph="none" pos="word" start_char="991">con</TOKEN>
<TOKEN end_char="996" id="token-4-58" morph="none" pos="word" start_char="995">al</TOKEN>
<TOKEN end_char="1002" id="token-4-59" morph="none" pos="word" start_char="998">menos</TOKEN>
<TOKEN end_char="1006" id="token-4-60" morph="none" pos="word" start_char="1004">uno</TOKEN>
<TOKEN end_char="1009" id="token-4-61" morph="none" pos="word" start_char="1008">de</TOKEN>
<TOKEN end_char="1013" id="token-4-62" morph="none" pos="word" start_char="1011">los</TOKEN>
<TOKEN end_char="1023" id="token-4-63" morph="none" pos="word" start_char="1015">siguiente</TOKEN>
<TOKEN end_char="1033" id="token-4-64" morph="none" pos="word" start_char="1025">criterios</TOKEN>
<TOKEN end_char="1034" id="token-4-65" morph="none" pos="punct" start_char="1034">:</TOKEN>
<TOKEN end_char="1037" id="token-4-66" morph="none" pos="word" start_char="1036">un</TOKEN>
<TOKEN end_char="1041" id="token-4-67" morph="none" pos="word" start_char="1039">IMC</TOKEN>
<TOKEN end_char="1046" id="token-4-68" morph="none" pos="unknown" start_char="1043">≥35,</TOKEN>
<TOKEN end_char="1057" id="token-4-69" morph="none" pos="word" start_char="1048">enfermedad</TOKEN>
<TOKEN end_char="1063" id="token-4-70" morph="none" pos="word" start_char="1059">renal</TOKEN>
<TOKEN end_char="1071" id="token-4-71" morph="none" pos="word" start_char="1065">crónica</TOKEN>
<TOKEN end_char="1072" id="token-4-72" morph="none" pos="punct" start_char="1072">,</TOKEN>
<TOKEN end_char="1081" id="token-4-73" morph="none" pos="word" start_char="1074">diabetes</TOKEN>
<TOKEN end_char="1082" id="token-4-74" morph="none" pos="punct" start_char="1082">,</TOKEN>
<TOKEN end_char="1086" id="token-4-75" morph="none" pos="word" start_char="1084">una</TOKEN>
<TOKEN end_char="1097" id="token-4-76" morph="none" pos="word" start_char="1088">enfermedad</TOKEN>
<TOKEN end_char="1113" id="token-4-77" morph="none" pos="word" start_char="1099">inmunosupresora</TOKEN>
<TOKEN end_char="1114" id="token-4-78" morph="none" pos="punct" start_char="1114">,</TOKEN>
<TOKEN end_char="1122" id="token-4-79" morph="none" pos="word" start_char="1116">reciben</TOKEN>
<TOKEN end_char="1134" id="token-4-80" morph="none" pos="word" start_char="1124">tratamiento</TOKEN>
<TOKEN end_char="1149" id="token-4-81" morph="none" pos="word" start_char="1136">inmunosupresor</TOKEN>
<TOKEN end_char="1150" id="token-4-82" morph="none" pos="punct" start_char="1150">,</TOKEN>
<TOKEN end_char="1154" id="token-4-83" morph="none" pos="unknown" start_char="1152">≥65</TOKEN>
<TOKEN end_char="1159" id="token-4-84" morph="none" pos="word" start_char="1156">años</TOKEN>
<TOKEN end_char="1160" id="token-4-85" morph="none" pos="punct" start_char="1160">,</TOKEN>
<TOKEN end_char="1164" id="token-4-86" morph="none" pos="unknown" start_char="1162">≥55</TOKEN>
<TOKEN end_char="1169" id="token-4-87" morph="none" pos="word" start_char="1166">años</TOKEN>
<TOKEN end_char="1173" id="token-4-88" morph="none" pos="word" start_char="1171">que</TOKEN>
<TOKEN end_char="1179" id="token-4-89" morph="none" pos="word" start_char="1175">tiene</TOKEN>
<TOKEN end_char="1190" id="token-4-90" morph="none" pos="word" start_char="1181">enfermedad</TOKEN>
<TOKEN end_char="1205" id="token-4-91" morph="none" pos="word" start_char="1192">cardiovascular</TOKEN>
<TOKEN end_char="1206" id="token-4-92" morph="none" pos="punct" start_char="1206">,</TOKEN>
<TOKEN end_char="1219" id="token-4-93" morph="none" pos="word" start_char="1208">hipertensión</TOKEN>
<TOKEN end_char="1221" id="token-4-94" morph="none" pos="word" start_char="1221">o</TOKEN>
<TOKEN end_char="1225" id="token-4-95" morph="none" pos="word" start_char="1223">una</TOKEN>
<TOKEN end_char="1236" id="token-4-96" morph="none" pos="word" start_char="1227">enfermedad</TOKEN>
<TOKEN end_char="1245" id="token-4-97" morph="none" pos="word" start_char="1238">pulmonar</TOKEN>
<TOKEN end_char="1257" id="token-4-98" morph="none" pos="word" start_char="1247">obstructiva</TOKEN>
<TOKEN end_char="1265" id="token-4-99" morph="none" pos="word" start_char="1259">crónica</TOKEN>
<TOKEN end_char="1266" id="token-4-100" morph="none" pos="punct" start_char="1266">,</TOKEN>
<TOKEN end_char="1272" id="token-4-101" morph="none" pos="word" start_char="1268">entre</TOKEN>
<TOKEN end_char="1278" id="token-4-102" morph="none" pos="word" start_char="1274">otros</TOKEN>
<TOKEN end_char="1280" id="token-4-103" morph="none" pos="punct" start_char="1279">).</TOKEN>
<TRANSLATED_TEXT>Bamlanivimab is authorised for the treatment of Covid-19 from mild to moderate, in adult and pediatric patients with positive results from direct viral tests of SARS-CoV-2, who are 12 years of age or older and weigh at least 40 kg, with a high risk of progression to severe COVID-19 and / or hospitalization (with at least one of the following criteria: BMI ≥ 35, chronic disease, diabetes, an immunosuppressive kidney disease, receiving immunosuppressive treatment, ≥ 65, ≥ 55 years of cardiovascular disease, hypertension or chronic obstructive pulmonary disease, among others).</TRANSLATED_TEXT><DETECTED_LANGUAGE>es</DETECTED_LANGUAGE></SEG>
<SEG end_char="1343" id="segment-5" start_char="1283">
<ORIGINAL_TEXT>La EUA emitida a bamlanivimab se basa en un ensayo de fase 2.</ORIGINAL_TEXT>
<TOKEN end_char="1284" id="token-5-0" morph="none" pos="word" start_char="1283">La</TOKEN>
<TOKEN end_char="1288" id="token-5-1" morph="none" pos="word" start_char="1286">EUA</TOKEN>
<TOKEN end_char="1296" id="token-5-2" morph="none" pos="word" start_char="1290">emitida</TOKEN>
<TOKEN end_char="1298" id="token-5-3" morph="none" pos="word" start_char="1298">a</TOKEN>
<TOKEN end_char="1311" id="token-5-4" morph="none" pos="word" start_char="1300">bamlanivimab</TOKEN>
<TOKEN end_char="1314" id="token-5-5" morph="none" pos="word" start_char="1313">se</TOKEN>
<TOKEN end_char="1319" id="token-5-6" morph="none" pos="word" start_char="1316">basa</TOKEN>
<TOKEN end_char="1322" id="token-5-7" morph="none" pos="word" start_char="1321">en</TOKEN>
<TOKEN end_char="1325" id="token-5-8" morph="none" pos="word" start_char="1324">un</TOKEN>
<TOKEN end_char="1332" id="token-5-9" morph="none" pos="word" start_char="1327">ensayo</TOKEN>
<TOKEN end_char="1335" id="token-5-10" morph="none" pos="word" start_char="1334">de</TOKEN>
<TOKEN end_char="1340" id="token-5-11" morph="none" pos="word" start_char="1337">fase</TOKEN>
<TOKEN end_char="1342" id="token-5-12" morph="none" pos="word" start_char="1342">2</TOKEN>
<TOKEN end_char="1343" id="token-5-13" morph="none" pos="punct" start_char="1343">.</TOKEN>
<TRANSLATED_TEXT>The US issued to bamlanivimab is based on a Phase 2 trial.</TRANSLATED_TEXT><DETECTED_LANGUAGE>es</DETECTED_LANGUAGE></SEG>
<SEG end_char="1552" id="segment-6" start_char="1345">
<ORIGINAL_TEXT>La evidencia más importante de que bamlanivimab puede ser eficaz proviene de la reducción de hospitalizaciones o visitas a la sala de emergencias por COVID-19 dentro de los 28 días posteriores al tratamiento.</ORIGINAL_TEXT>
<TOKEN end_char="1346" id="token-6-0" morph="none" pos="word" start_char="1345">La</TOKEN>
<TOKEN end_char="1356" id="token-6-1" morph="none" pos="word" start_char="1348">evidencia</TOKEN>
<TOKEN end_char="1360" id="token-6-2" morph="none" pos="word" start_char="1358">más</TOKEN>
<TOKEN end_char="1371" id="token-6-3" morph="none" pos="word" start_char="1362">importante</TOKEN>
<TOKEN end_char="1374" id="token-6-4" morph="none" pos="word" start_char="1373">de</TOKEN>
<TOKEN end_char="1378" id="token-6-5" morph="none" pos="word" start_char="1376">que</TOKEN>
<TOKEN end_char="1391" id="token-6-6" morph="none" pos="word" start_char="1380">bamlanivimab</TOKEN>
<TOKEN end_char="1397" id="token-6-7" morph="none" pos="word" start_char="1393">puede</TOKEN>
<TOKEN end_char="1401" id="token-6-8" morph="none" pos="word" start_char="1399">ser</TOKEN>
<TOKEN end_char="1408" id="token-6-9" morph="none" pos="word" start_char="1403">eficaz</TOKEN>
<TOKEN end_char="1417" id="token-6-10" morph="none" pos="word" start_char="1410">proviene</TOKEN>
<TOKEN end_char="1420" id="token-6-11" morph="none" pos="word" start_char="1419">de</TOKEN>
<TOKEN end_char="1423" id="token-6-12" morph="none" pos="word" start_char="1422">la</TOKEN>
<TOKEN end_char="1433" id="token-6-13" morph="none" pos="word" start_char="1425">reducción</TOKEN>
<TOKEN end_char="1436" id="token-6-14" morph="none" pos="word" start_char="1435">de</TOKEN>
<TOKEN end_char="1454" id="token-6-15" morph="none" pos="word" start_char="1438">hospitalizaciones</TOKEN>
<TOKEN end_char="1456" id="token-6-16" morph="none" pos="word" start_char="1456">o</TOKEN>
<TOKEN end_char="1464" id="token-6-17" morph="none" pos="word" start_char="1458">visitas</TOKEN>
<TOKEN end_char="1466" id="token-6-18" morph="none" pos="word" start_char="1466">a</TOKEN>
<TOKEN end_char="1469" id="token-6-19" morph="none" pos="word" start_char="1468">la</TOKEN>
<TOKEN end_char="1474" id="token-6-20" morph="none" pos="word" start_char="1471">sala</TOKEN>
<TOKEN end_char="1477" id="token-6-21" morph="none" pos="word" start_char="1476">de</TOKEN>
<TOKEN end_char="1489" id="token-6-22" morph="none" pos="word" start_char="1479">emergencias</TOKEN>
<TOKEN end_char="1493" id="token-6-23" morph="none" pos="word" start_char="1491">por</TOKEN>
<TOKEN end_char="1502" id="token-6-24" morph="none" pos="unknown" start_char="1495">COVID-19</TOKEN>
<TOKEN end_char="1509" id="token-6-25" morph="none" pos="word" start_char="1504">dentro</TOKEN>
<TOKEN end_char="1512" id="token-6-26" morph="none" pos="word" start_char="1511">de</TOKEN>
<TOKEN end_char="1516" id="token-6-27" morph="none" pos="word" start_char="1514">los</TOKEN>
<TOKEN end_char="1519" id="token-6-28" morph="none" pos="word" start_char="1518">28</TOKEN>
<TOKEN end_char="1524" id="token-6-29" morph="none" pos="word" start_char="1521">días</TOKEN>
<TOKEN end_char="1536" id="token-6-30" morph="none" pos="word" start_char="1526">posteriores</TOKEN>
<TOKEN end_char="1539" id="token-6-31" morph="none" pos="word" start_char="1538">al</TOKEN>
<TOKEN end_char="1551" id="token-6-32" morph="none" pos="word" start_char="1541">tratamiento</TOKEN>
<TOKEN end_char="1552" id="token-6-33" morph="none" pos="punct" start_char="1552">.</TOKEN>
<TRANSLATED_TEXT>The most important evidence that bamlanivimab can be effective comes from reduced hospitalizations or visits to the emergency room by COVID-19 within 28 days of treatment.</TRANSLATED_TEXT><DETECTED_LANGUAGE>es</DETECTED_LANGUAGE></SEG>
<SEG end_char="1764" id="segment-7" start_char="1554">
<ORIGINAL_TEXT>Para los pacientes con alto riesgo de progresión de la enfermedad, se produjeron hospitalizaciones y visitas a la sala de emergencias en un promedio del 3% con bamlanivimab en comparación con el 10% con placebo.</ORIGINAL_TEXT>
<TOKEN end_char="1557" id="token-7-0" morph="none" pos="word" start_char="1554">Para</TOKEN>
<TOKEN end_char="1561" id="token-7-1" morph="none" pos="word" start_char="1559">los</TOKEN>
<TOKEN end_char="1571" id="token-7-2" morph="none" pos="word" start_char="1563">pacientes</TOKEN>
<TOKEN end_char="1575" id="token-7-3" morph="none" pos="word" start_char="1573">con</TOKEN>
<TOKEN end_char="1580" id="token-7-4" morph="none" pos="word" start_char="1577">alto</TOKEN>
<TOKEN end_char="1587" id="token-7-5" morph="none" pos="word" start_char="1582">riesgo</TOKEN>
<TOKEN end_char="1590" id="token-7-6" morph="none" pos="word" start_char="1589">de</TOKEN>
<TOKEN end_char="1601" id="token-7-7" morph="none" pos="word" start_char="1592">progresión</TOKEN>
<TOKEN end_char="1604" id="token-7-8" morph="none" pos="word" start_char="1603">de</TOKEN>
<TOKEN end_char="1607" id="token-7-9" morph="none" pos="word" start_char="1606">la</TOKEN>
<TOKEN end_char="1618" id="token-7-10" morph="none" pos="word" start_char="1609">enfermedad</TOKEN>
<TOKEN end_char="1619" id="token-7-11" morph="none" pos="punct" start_char="1619">,</TOKEN>
<TOKEN end_char="1622" id="token-7-12" morph="none" pos="word" start_char="1621">se</TOKEN>
<TOKEN end_char="1633" id="token-7-13" morph="none" pos="word" start_char="1624">produjeron</TOKEN>
<TOKEN end_char="1651" id="token-7-14" morph="none" pos="word" start_char="1635">hospitalizaciones</TOKEN>
<TOKEN end_char="1653" id="token-7-15" morph="none" pos="word" start_char="1653">y</TOKEN>
<TOKEN end_char="1661" id="token-7-16" morph="none" pos="word" start_char="1655">visitas</TOKEN>
<TOKEN end_char="1663" id="token-7-17" morph="none" pos="word" start_char="1663">a</TOKEN>
<TOKEN end_char="1666" id="token-7-18" morph="none" pos="word" start_char="1665">la</TOKEN>
<TOKEN end_char="1671" id="token-7-19" morph="none" pos="word" start_char="1668">sala</TOKEN>
<TOKEN end_char="1674" id="token-7-20" morph="none" pos="word" start_char="1673">de</TOKEN>
<TOKEN end_char="1686" id="token-7-21" morph="none" pos="word" start_char="1676">emergencias</TOKEN>
<TOKEN end_char="1689" id="token-7-22" morph="none" pos="word" start_char="1688">en</TOKEN>
<TOKEN end_char="1692" id="token-7-23" morph="none" pos="word" start_char="1691">un</TOKEN>
<TOKEN end_char="1701" id="token-7-24" morph="none" pos="word" start_char="1694">promedio</TOKEN>
<TOKEN end_char="1705" id="token-7-25" morph="none" pos="word" start_char="1703">del</TOKEN>
<TOKEN end_char="1707" id="token-7-26" morph="none" pos="word" start_char="1707">3</TOKEN>
<TOKEN end_char="1708" id="token-7-27" morph="none" pos="punct" start_char="1708">%</TOKEN>
<TOKEN end_char="1712" id="token-7-28" morph="none" pos="word" start_char="1710">con</TOKEN>
<TOKEN end_char="1725" id="token-7-29" morph="none" pos="word" start_char="1714">bamlanivimab</TOKEN>
<TOKEN end_char="1728" id="token-7-30" morph="none" pos="word" start_char="1727">en</TOKEN>
<TOKEN end_char="1740" id="token-7-31" morph="none" pos="word" start_char="1730">comparación</TOKEN>
<TOKEN end_char="1744" id="token-7-32" morph="none" pos="word" start_char="1742">con</TOKEN>
<TOKEN end_char="1747" id="token-7-33" morph="none" pos="word" start_char="1746">el</TOKEN>
<TOKEN end_char="1750" id="token-7-34" morph="none" pos="word" start_char="1749">10</TOKEN>
<TOKEN end_char="1751" id="token-7-35" morph="none" pos="punct" start_char="1751">%</TOKEN>
<TOKEN end_char="1755" id="token-7-36" morph="none" pos="word" start_char="1753">con</TOKEN>
<TOKEN end_char="1763" id="token-7-37" morph="none" pos="word" start_char="1757">placebo</TOKEN>
<TOKEN end_char="1764" id="token-7-38" morph="none" pos="punct" start_char="1764">.</TOKEN>
<TRANSLATED_TEXT>For patients at high risk of disease progression, hospitalizations and emergency room visits averaged 3% with bamlanivimab compared to 10% with placebo.</TRANSLATED_TEXT><DETECTED_LANGUAGE>es</DETECTED_LANGUAGE></SEG>
<SEG end_char="1865" id="segment-8" start_char="1766">
<ORIGINAL_TEXT>La EUA permite que bamlanivimab se distribuya y administre como una dosis única por vía intravenosa.</ORIGINAL_TEXT>
<TOKEN end_char="1767" id="token-8-0" morph="none" pos="word" start_char="1766">La</TOKEN>
<TOKEN end_char="1771" id="token-8-1" morph="none" pos="word" start_char="1769">EUA</TOKEN>
<TOKEN end_char="1779" id="token-8-2" morph="none" pos="word" start_char="1773">permite</TOKEN>
<TOKEN end_char="1783" id="token-8-3" morph="none" pos="word" start_char="1781">que</TOKEN>
<TOKEN end_char="1796" id="token-8-4" morph="none" pos="word" start_char="1785">bamlanivimab</TOKEN>
<TOKEN end_char="1799" id="token-8-5" morph="none" pos="word" start_char="1798">se</TOKEN>
<TOKEN end_char="1810" id="token-8-6" morph="none" pos="word" start_char="1801">distribuya</TOKEN>
<TOKEN end_char="1812" id="token-8-7" morph="none" pos="word" start_char="1812">y</TOKEN>
<TOKEN end_char="1823" id="token-8-8" morph="none" pos="word" start_char="1814">administre</TOKEN>
<TOKEN end_char="1828" id="token-8-9" morph="none" pos="word" start_char="1825">como</TOKEN>
<TOKEN end_char="1832" id="token-8-10" morph="none" pos="word" start_char="1830">una</TOKEN>
<TOKEN end_char="1838" id="token-8-11" morph="none" pos="word" start_char="1834">dosis</TOKEN>
<TOKEN end_char="1844" id="token-8-12" morph="none" pos="word" start_char="1840">única</TOKEN>
<TOKEN end_char="1848" id="token-8-13" morph="none" pos="word" start_char="1846">por</TOKEN>
<TOKEN end_char="1852" id="token-8-14" morph="none" pos="word" start_char="1850">vía</TOKEN>
<TOKEN end_char="1864" id="token-8-15" morph="none" pos="word" start_char="1854">intravenosa</TOKEN>
<TOKEN end_char="1865" id="token-8-16" morph="none" pos="punct" start_char="1865">.</TOKEN>
<TRANSLATED_TEXT>The US allows bamlanivimab to be distributed and administered as a single dose intravenously.</TRANSLATED_TEXT><DETECTED_LANGUAGE>es</DETECTED_LANGUAGE></SEG>
<SEG end_char="2120" id="segment-9" start_char="1868">
<ORIGINAL_TEXT>Las reacciones adversas relacionadas con la infusión de bamlanivimab pueden incluir: fiebre, escalofríos, náuseas, dolor de cabeza, broncoespasmo, hipotensión, angioedema, irritación de garganta, erupción incluyendo urticaria, prurito, mialgia y mareos.</ORIGINAL_TEXT>
<TOKEN end_char="1870" id="token-9-0" morph="none" pos="word" start_char="1868">Las</TOKEN>
<TOKEN end_char="1881" id="token-9-1" morph="none" pos="word" start_char="1872">reacciones</TOKEN>
<TOKEN end_char="1890" id="token-9-2" morph="none" pos="word" start_char="1883">adversas</TOKEN>
<TOKEN end_char="1903" id="token-9-3" morph="none" pos="word" start_char="1892">relacionadas</TOKEN>
<TOKEN end_char="1907" id="token-9-4" morph="none" pos="word" start_char="1905">con</TOKEN>
<TOKEN end_char="1910" id="token-9-5" morph="none" pos="word" start_char="1909">la</TOKEN>
<TOKEN end_char="1919" id="token-9-6" morph="none" pos="word" start_char="1912">infusión</TOKEN>
<TOKEN end_char="1922" id="token-9-7" morph="none" pos="word" start_char="1921">de</TOKEN>
<TOKEN end_char="1935" id="token-9-8" morph="none" pos="word" start_char="1924">bamlanivimab</TOKEN>
<TOKEN end_char="1942" id="token-9-9" morph="none" pos="word" start_char="1937">pueden</TOKEN>
<TOKEN end_char="1950" id="token-9-10" morph="none" pos="word" start_char="1944">incluir</TOKEN>
<TOKEN end_char="1951" id="token-9-11" morph="none" pos="punct" start_char="1951">:</TOKEN>
<TOKEN end_char="1958" id="token-9-12" morph="none" pos="word" start_char="1953">fiebre</TOKEN>
<TOKEN end_char="1959" id="token-9-13" morph="none" pos="punct" start_char="1959">,</TOKEN>
<TOKEN end_char="1971" id="token-9-14" morph="none" pos="word" start_char="1961">escalofríos</TOKEN>
<TOKEN end_char="1972" id="token-9-15" morph="none" pos="punct" start_char="1972">,</TOKEN>
<TOKEN end_char="1980" id="token-9-16" morph="none" pos="word" start_char="1974">náuseas</TOKEN>
<TOKEN end_char="1981" id="token-9-17" morph="none" pos="punct" start_char="1981">,</TOKEN>
<TOKEN end_char="1987" id="token-9-18" morph="none" pos="word" start_char="1983">dolor</TOKEN>
<TOKEN end_char="1990" id="token-9-19" morph="none" pos="word" start_char="1989">de</TOKEN>
<TOKEN end_char="1997" id="token-9-20" morph="none" pos="word" start_char="1992">cabeza</TOKEN>
<TOKEN end_char="1998" id="token-9-21" morph="none" pos="punct" start_char="1998">,</TOKEN>
<TOKEN end_char="2012" id="token-9-22" morph="none" pos="word" start_char="2000">broncoespasmo</TOKEN>
<TOKEN end_char="2013" id="token-9-23" morph="none" pos="punct" start_char="2013">,</TOKEN>
<TOKEN end_char="2025" id="token-9-24" morph="none" pos="word" start_char="2015">hipotensión</TOKEN>
<TOKEN end_char="2026" id="token-9-25" morph="none" pos="punct" start_char="2026">,</TOKEN>
<TOKEN end_char="2037" id="token-9-26" morph="none" pos="word" start_char="2028">angioedema</TOKEN>
<TOKEN end_char="2038" id="token-9-27" morph="none" pos="punct" start_char="2038">,</TOKEN>
<TOKEN end_char="2049" id="token-9-28" morph="none" pos="word" start_char="2040">irritación</TOKEN>
<TOKEN end_char="2052" id="token-9-29" morph="none" pos="word" start_char="2051">de</TOKEN>
<TOKEN end_char="2061" id="token-9-30" morph="none" pos="word" start_char="2054">garganta</TOKEN>
<TOKEN end_char="2062" id="token-9-31" morph="none" pos="punct" start_char="2062">,</TOKEN>
<TOKEN end_char="2071" id="token-9-32" morph="none" pos="word" start_char="2064">erupción</TOKEN>
<TOKEN end_char="2082" id="token-9-33" morph="none" pos="word" start_char="2073">incluyendo</TOKEN>
<TOKEN end_char="2092" id="token-9-34" morph="none" pos="word" start_char="2084">urticaria</TOKEN>
<TOKEN end_char="2093" id="token-9-35" morph="none" pos="punct" start_char="2093">,</TOKEN>
<TOKEN end_char="2101" id="token-9-36" morph="none" pos="word" start_char="2095">prurito</TOKEN>
<TOKEN end_char="2102" id="token-9-37" morph="none" pos="punct" start_char="2102">,</TOKEN>
<TOKEN end_char="2110" id="token-9-38" morph="none" pos="word" start_char="2104">mialgia</TOKEN>
<TOKEN end_char="2112" id="token-9-39" morph="none" pos="word" start_char="2112">y</TOKEN>
<TOKEN end_char="2119" id="token-9-40" morph="none" pos="word" start_char="2114">mareos</TOKEN>
<TOKEN end_char="2120" id="token-9-41" morph="none" pos="punct" start_char="2120">.</TOKEN>
<TRANSLATED_TEXT>Adverse reactions related to the infusion of bamlanivimab may include: fever, chills, nausea, headache, bronchospasm, hypotension, angioedema, throat irritation, rash including urticaria, pruritus, myalgia and dizziness.</TRANSLATED_TEXT><DETECTED_LANGUAGE>es</DETECTED_LANGUAGE></SEG>
<SEG end_char="2444" id="segment-10" start_char="2123">
<ORIGINAL_TEXT>Bamlanivimab no está autorizado para pacientes hospitalizados o que requieran oxigenoterapia debido a la COVID-19; a diferencia del antiviral remdesivir (primer tratamiento para la COVID-19 aprobado por la FDA), que está autorizado para el tratamiento de la COVID-19 en adultos y pediátricos que requieran hospitalización.</ORIGINAL_TEXT>
<TOKEN end_char="2134" id="token-10-0" morph="none" pos="word" start_char="2123">Bamlanivimab</TOKEN>
<TOKEN end_char="2137" id="token-10-1" morph="none" pos="word" start_char="2136">no</TOKEN>
<TOKEN end_char="2142" id="token-10-2" morph="none" pos="word" start_char="2139">está</TOKEN>
<TOKEN end_char="2153" id="token-10-3" morph="none" pos="word" start_char="2144">autorizado</TOKEN>
<TOKEN end_char="2158" id="token-10-4" morph="none" pos="word" start_char="2155">para</TOKEN>
<TOKEN end_char="2168" id="token-10-5" morph="none" pos="word" start_char="2160">pacientes</TOKEN>
<TOKEN end_char="2183" id="token-10-6" morph="none" pos="word" start_char="2170">hospitalizados</TOKEN>
<TOKEN end_char="2185" id="token-10-7" morph="none" pos="word" start_char="2185">o</TOKEN>
<TOKEN end_char="2189" id="token-10-8" morph="none" pos="word" start_char="2187">que</TOKEN>
<TOKEN end_char="2199" id="token-10-9" morph="none" pos="word" start_char="2191">requieran</TOKEN>
<TOKEN end_char="2214" id="token-10-10" morph="none" pos="word" start_char="2201">oxigenoterapia</TOKEN>
<TOKEN end_char="2221" id="token-10-11" morph="none" pos="word" start_char="2216">debido</TOKEN>
<TOKEN end_char="2223" id="token-10-12" morph="none" pos="word" start_char="2223">a</TOKEN>
<TOKEN end_char="2226" id="token-10-13" morph="none" pos="word" start_char="2225">la</TOKEN>
<TOKEN end_char="2235" id="token-10-14" morph="none" pos="unknown" start_char="2228">COVID-19</TOKEN>
<TOKEN end_char="2236" id="token-10-15" morph="none" pos="punct" start_char="2236">;</TOKEN>
<TOKEN end_char="2238" id="token-10-16" morph="none" pos="word" start_char="2238">a</TOKEN>
<TOKEN end_char="2249" id="token-10-17" morph="none" pos="word" start_char="2240">diferencia</TOKEN>
<TOKEN end_char="2253" id="token-10-18" morph="none" pos="word" start_char="2251">del</TOKEN>
<TOKEN end_char="2263" id="token-10-19" morph="none" pos="word" start_char="2255">antiviral</TOKEN>
<TOKEN end_char="2274" id="token-10-20" morph="none" pos="word" start_char="2265">remdesivir</TOKEN>
<TOKEN end_char="2276" id="token-10-21" morph="none" pos="punct" start_char="2276">(</TOKEN>
<TOKEN end_char="2282" id="token-10-22" morph="none" pos="word" start_char="2277">primer</TOKEN>
<TOKEN end_char="2294" id="token-10-23" morph="none" pos="word" start_char="2284">tratamiento</TOKEN>
<TOKEN end_char="2299" id="token-10-24" morph="none" pos="word" start_char="2296">para</TOKEN>
<TOKEN end_char="2302" id="token-10-25" morph="none" pos="word" start_char="2301">la</TOKEN>
<TOKEN end_char="2311" id="token-10-26" morph="none" pos="unknown" start_char="2304">COVID-19</TOKEN>
<TOKEN end_char="2320" id="token-10-27" morph="none" pos="word" start_char="2313">aprobado</TOKEN>
<TOKEN end_char="2324" id="token-10-28" morph="none" pos="word" start_char="2322">por</TOKEN>
<TOKEN end_char="2327" id="token-10-29" morph="none" pos="word" start_char="2326">la</TOKEN>
<TOKEN end_char="2331" id="token-10-30" morph="none" pos="word" start_char="2329">FDA</TOKEN>
<TOKEN end_char="2333" id="token-10-31" morph="none" pos="punct" start_char="2332">),</TOKEN>
<TOKEN end_char="2337" id="token-10-32" morph="none" pos="word" start_char="2335">que</TOKEN>
<TOKEN end_char="2342" id="token-10-33" morph="none" pos="word" start_char="2339">está</TOKEN>
<TOKEN end_char="2353" id="token-10-34" morph="none" pos="word" start_char="2344">autorizado</TOKEN>
<TOKEN end_char="2358" id="token-10-35" morph="none" pos="word" start_char="2355">para</TOKEN>
<TOKEN end_char="2361" id="token-10-36" morph="none" pos="word" start_char="2360">el</TOKEN>
<TOKEN end_char="2373" id="token-10-37" morph="none" pos="word" start_char="2363">tratamiento</TOKEN>
<TOKEN end_char="2376" id="token-10-38" morph="none" pos="word" start_char="2375">de</TOKEN>
<TOKEN end_char="2379" id="token-10-39" morph="none" pos="word" start_char="2378">la</TOKEN>
<TOKEN end_char="2388" id="token-10-40" morph="none" pos="unknown" start_char="2381">COVID-19</TOKEN>
<TOKEN end_char="2391" id="token-10-41" morph="none" pos="word" start_char="2390">en</TOKEN>
<TOKEN end_char="2399" id="token-10-42" morph="none" pos="word" start_char="2393">adultos</TOKEN>
<TOKEN end_char="2401" id="token-10-43" morph="none" pos="word" start_char="2401">y</TOKEN>
<TOKEN end_char="2413" id="token-10-44" morph="none" pos="word" start_char="2403">pediátricos</TOKEN>
<TOKEN end_char="2417" id="token-10-45" morph="none" pos="word" start_char="2415">que</TOKEN>
<TOKEN end_char="2427" id="token-10-46" morph="none" pos="word" start_char="2419">requieran</TOKEN>
<TOKEN end_char="2443" id="token-10-47" morph="none" pos="word" start_char="2429">hospitalización</TOKEN>
<TOKEN end_char="2444" id="token-10-48" morph="none" pos="punct" start_char="2444">.</TOKEN>
<TRANSLATED_TEXT>Bamlanivimab is not authorized for patients hospitalized or requiring oxygen therapy due to COVID-19; unlike the antiviral remdesivir (the first FDA-approved treatment for COVID-19), it is authorized for the treatment of COVID-19 in adults and pediatric patients requiring hospitalization.</TRANSLATED_TEXT><DETECTED_LANGUAGE>es</DETECTED_LANGUAGE></SEG>
</TEXT>
</DOC>
</LCTL_TEXT>